Related Experiment Videos
The sentinel node in breast cancer--a multicenter validation study
1Cancer Center, Department of Surgery, University of Vermont, Burlington 05405, USA.
The New England Journal of Medicine
|October 1, 1998
Summary
Sentinel node biopsy accurately predicts breast cancer metastasis to axillary nodes. This radioactive tracer method identifies key lymph nodes, aiding surgical decisions and improving patient outcomes.
Area of Science:
- Oncology
- Surgical Oncology
- Nuclear Medicine
Background:
- Pilot studies suggest radioactive sentinel node biopsy identifies breast cancer metastases.
- A multicenter study was conducted to validate this technique across various surgical settings.
Purpose of the Study:
- To confirm the efficacy of probe-guided radioactive sentinel node resection in identifying regional metastases in breast cancer patients.
- To assess the accuracy and reliability of the sentinel node biopsy procedure.
Main Methods:
- 443 breast cancer patients were enrolled.
- Technetium-99m sulfur colloid was injected to identify sentinel nodes using a gamma probe.
- Sentinel nodes were resected, followed by complete axillary lymphadenectomy for comparison.
Main Results:
- Sentinel nodes were identified in 93% of patients.
- The sentinel node biopsy demonstrated 97% accuracy in predicting axillary node status.
- High values for specificity (100%), positive predictive value (100%), and negative predictive value (96%) were observed.
Conclusions:
- Sentinel node biopsy is a reliable method for predicting axillary lymph node metastasis in breast cancer.
- The procedure's success rate can be influenced by surgeon experience and patient-specific factors.
- While effective, the technique presents technical challenges.